Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older

NCT01884519 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults

NCT01144299 ·Status: COMPLETED ·Phase: PHASE3

Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™

NCT00377611 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate

NCT00363077 ·Status: COMPLETED ·Phase: PHASE2

A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults

NCT00363870 ·Status: COMPLETED ·Phase: PHASE4

Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines

NCT00197288 ·Status: COMPLETED ·Phase: PHASE3

Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

NCT00538473 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate

NCT00374842 ·Status: COMPLETED ·Phase: PHASE2

Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population

NCT00377585 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A)

NCT01204671 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

NCT00538213 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate an Influenza Vaccine Candidate

NCT00540228 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults

NCT00386698 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate an Influenza Vaccine Candidate

NCT00321373 ·Status: COMPLETED ·Phase: PHASE2

Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in Europe

NCT00479921 ·Status: COMPLETED ·Phase: PHASE3

Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate

NCT00321763 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate

NCT00385840 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects

NCT00748150 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix

NCT00693706 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population

NCT00318149 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older

NCT01878812 ·Status: COMPLETED ·Phase: PHASE3

Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

NCT00529516 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine

NCT00491257 ·Status: COMPLETED ·Phase: PHASE2

Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine

NCT00197223 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine

NCT00343681 ·Status: COMPLETED ·Phase: PHASE2